SFI
WHWK

Susquehanna Fundamental Investments’s Whitehawk Therapeutics WHWK Stock Holding History

Susquehanna Fundamental Investments’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-733
Closed -$11K – 1639
2020
Q4 		$11K Buy
+733
New +$15.7K ﹤0.01% 1470

Other funds holding WHWK

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SAM
Scion Asset Management Saratoga, California $1.38B AUM 43.96% 1-Year Est. Return

Susquehanna Fundamental Investments's WHWK Position: Q1 2021 in Review

Susquehanna Fundamental Investments sold out of Whitehawk Therapeutics (WHWK) in Q1 2021, closing a stake of 733 shares — an estimated $11K sold.

Susquehanna Fundamental Investments first reported a position in WHWK in Q4 2020 and held it in 1 quarter. The position peaked at $11K in Q4 2020. 42 funds tracked by Wall St. Rank hold WHWK as of Q1 2021.

  • Susquehanna Fundamental Investments reported no remaining Whitehawk Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 733 Whitehawk Therapeutics shares in Q1 2021, an estimated $11K.
  • Susquehanna Fundamental Investments first reported a position in Whitehawk Therapeutics in Q4 2020 and held it in 1 quarter.
  • Susquehanna Fundamental Investments's Whitehawk Therapeutics position peaked at $11K in Q4 2020.
  • 42 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2021, filed 17 May 2021.